Department of Biostatistics Archives
Nov. 10, 2023—A Vanderbilt team team will develop and test new clinical decision support tools to facilitate timely prevention of potentially lethal hospital-acquired blood clots, also known as venous thromboembolism.
Nov. 8, 2023—Vanderbilt's Dandan Liu, PhD, has been elected president of the Association of Clinical and Translational Statisticians.
Oct. 20, 2023—Vanderbilt's Bryan Shepherd, PhDhas received a MERIT Award, or Method to Extend Research in Time Award, from the National Institute of Allergy and Infectious Diseases.
Oct. 17, 2023—An artificial intelligence tool developed at Vanderbilt accurately identified pediatric patients at high risk for blood clots in a clinical trial, with no difference in outcomes compared to a control group.
Oct. 17, 2023—Biostatisticians at VUMC have played a pivotal role in the redesign of clinical trials that rigorously and rapidly determine the effectiveness of life-saving treatments for acutely ill patients.
Aug. 2, 2023—Researchers at Vanderbilt University Medical Center have received a four-year, $28 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to study the relationship between COVID-19 and diabetes.
Jul. 17, 2023—Vanderbilt University Medical Center's Academy for Excellence in Education has elected 13 new members for 2023.
Feb. 23, 2023—A recent systematic review by Vanderbilt researchers has taken a close look at the cognitive instruments used in long-term outcome studies of survivors of adult critical illness and how those test scores are interpreted.
Jan. 26, 2023—Vanderbilt University Medical Center has established a first-of-its-kind Center for Learning Healthcare that will bring together clinicians, health system operations leaders and researchers to generate evidence in the course of health care delivery to continuously improve the quality, value and safety of health care offered to patients.
Jul. 28, 2022—Just one-third of patients with relapsing multiple sclerosis remain on disease-modifying therapy, and specialty pharmacists are in a unique position to help coordinate therapy discontinuation or change and reduce the risk of relapse.
Jul. 21, 2022—The Vanderbilt Epidemiology PhD Program has received accreditation from the Council on Education for Public Health (CEPH).